Atlas Trials

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

Clinical trial NCT02143219 · COMPLETED

Trial details

NCT number
NCT02143219
Sponsor
Institut Cancerologie de l'Ouest
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Metastatic CancerToxicity
Start date
2014-07-31
Primary completion
2020-11-25
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.